BIOGEN INC. (BIIB)
Clinical trial NCT04292574 updates: 1. completion date: 2025-05-31 → 2040-01-01 2. primary completion date: 2025-05-31 → 2040-01-01
Clinical trial NCT04292574 updates: 1. completion date: 2025-05-31 → 2040-01-01 2. primary completion date: 2025-05-31 → 2040-01-01
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical